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OBJECTIVES: To evaluate the effects of intrathecal morphine on pulmonary function, analgesia, and morphine plasma concen-
trations after cardiac surgery. 
INTRODUCTION: Lung dysfunction increases morbidity and mortality after cardiac surgery. Regional analgesia may improve 
pulmonary outcomes by reducing pain, but the occurrence of this benefit remains controversial. 
METHODS: Forty-two patients were randomized for general anesthesia (control group n=22) or 400 µg of intrathecal morphine 
followed by general anesthesia (morphine group n=20). Postoperative analgesia was accomplished with an intravenous, patient-
controlled morphine pump. Blood gas measurements, forced vital capacity (FVC), forced expiratory volume (FEV), and FVC/FEV 
ratio were obtained preoperatively, as well as on the first and second postoperative days. Pain at rest, profound inspiration, amount 
of coughing, morphine solicitation, consumption, and plasma morphine concentration were evaluated for 36 hours postoperatively. 
Statistical analyses were performed using the repeated measures ANOVA or Mann-Whiney tests (*p<0.05). 
RESULTS: Both groups experienced reduced FVC postoperatively (3.24 L to 1.38 L in control group; 2.72 L to 1.18 L in morphine 
group), with no significant decreases observed between groups. The two groups also exhibited similar results for FEV1 (p=0.085), 
FEV1/FVC (p=0.68) and PaO2/FiO2 ratio (p=0.08). The morphine group reported less pain intensity (evaluated using a visual numeric 
scale), especially when coughing (18 hours postoperatively: control group= 4.73 and morphine group= 1.80, p=0.001). Cumula-
tive morphine consumption was reduced after 18 hours in the morphine group (control group= 20.14 and morphine group= 14.20 
mg, p=0.037). The plasma morphine concentration was also reduced in the morphine group 24 hours after surgery (control group= 
15.87 ng.mL-1 and morphine group= 4.08 ng.mL-1, p=0.029). 
CONCLUSIONS: Intrathecal morphine administration did not significantly alter pulmonary function; however, it improved patient 
analgesia and reduced morphine consumption and morphine plasma concentration.
KEYWORDS: Respiratory mechanics; Gas exchange; Cardiac surgery; Pain scores.
INTRODUCTION
Lung dysfunction after cardiac surgery is the most 
frequently reported cause of postoperative morbidity.1,2 In 
fact, postoperative atelectasis occurs more frequently in 
patients undergoing cardiac surgery with cardiopulmonary 
bypass (CPB) than in any other type of surgery3 In patients 
undergoing cardiac surgery, death caused by respiratory 
complications has been reported as being more frequent than 
that due to cardiac causes.4 Adequate perioperative analgesia 
enables full expansion of the chest, thereby contributing to 
reduce lung collapse in spontaneously breathing patients. 
This therapeutic intervention may reduce morbidity, hospital 
costs, and length of stay, thus improving patient quality of 
life and reducing the incidence of chronic pain.5 
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The impact of postoperative regional analgesia on 
major outcomes in non-cardiac surgery has been studied.6-8 
Small doses of opioids administered to the central nervous 
system provide adequate analgesia, reducing the risks of 
intravenous analgesic administration, such as respiratory 
depression, pruritus, nausea, and vomiting. However, in the 
cardiac surgical population, regional anesthesia techniques 
are not routinely applied due to the scarcity of supporting 
studies and administration risks associated with preoperative 
systemic anticoagulation9 Low doses of intrathecal morphine 
used to control postoperative pain has been shown to 
promote prolonged analgesia,5 and has been associated 
with a lower risk of hematoma formation compared to the 
epidural technique.10 Intrathecal morphine has been studied 
for several years in patients undergoing cardiac surgery, but 
these studies were primarily directed towards evaluation of 
pain control and hemodynamic stability, and did not consider 
its possible impact of intrathecal morphine on respiratory 
function recovery.11 
The objective of this study was to evaluate the effects of 
intrathecal morphine on pulmonary function, postoperative 
analgesia, and morphine plasma concentrations in patients 
undergoing coronary artery bypass surgery (CABG) with 
cardiopulmonary bypass (CPB) in comparison to standard 
intravenous analgesia.
MATERIALS AND METHODS
After approval of the hospital ethics committee and 
collection of free informed consent, forty-two patients 
undergoing CABG with CPB and ranging in age from 
18 to 80 years were included. Exclusion criteria were an 
ejection fraction below 40%, contraindications to neuraxial 
blockage, coagulopathy, use of low-weight heparin, warfarin, 
intrathecal morphine, or a platelet aggregation inhibitor 
other than aspirin, systemic or local infection, combined 
procedures, and patients with a specific contraindication to 
the medication employed in this study. Preoperative aspirin 
use was not an exclusion criterion. Preoperative surgical 
risk was evaluated using Higgins Surgical Risk Scale for 
cardiac surgery, and patients were considered: (1) minimum 
risk, (2) low risk, (3) moderate, (4) high, (5) extreme risk12. 
The patients were randomly assigned to receive general 
anesthesia with prior administration of intrathecal morphine 
at a dosage of 400 µg (morphine group n=20) or general 
anesthesia alone (control group n=22) according to a simple 
computer-generated list. 
Anesthesia and surgical procedures
On the day of the operation, the patients received 1 to 
2 mg kg -1 of midazolam orally 30 minutes before surgery, 
up to a maximal dose of 15 mg. Patients were monitored 
by continuous ECG and ST-analysis, pulse oximetry, and 
an invasive arterial line inserted in the right radial artery. 
In the morphine group, a 400-µg intrathecal injection of 
morphine was administered using a 27-gauge spinal needle 
in the L3-L4 space prior to induction of general anesthesia. 
If intrathecal puncture was not successful after two attempts, 
the patient was excluded from the study.
After pre-oxygenation, general anesthesia was induced 
using 0.3 mg/kg of hypnomidate, 0.1 mg kg-1 of pancuroniun 
bromide, and 0.5 µg kg-1 of sufentanil first as a bolus, 
followed by a continuous infusion at 0.5 µg kg-1 h-1. 
Mechanical ventilation was initiated using a Cícero 
ventilator (Dräger®, Germany) with a tidal volume of 8 
ml kg-1, respiratory frequency of 12 ipm, oxygen inspired 
fraction of 0.6%, and 5 cm of H2O PEEP. A nasoesophageal 
thermometer, bladder catheter, and central venous catheter 
were inserted after anesthesia induction. When judged 
necessary by the attending anesthesiologist, a pulmonary 
artery catheter was placed in the right internal jugular vein. 
Immediately after intubation and after CPB weaning, a lung 
expansion maneuver using an airway pressure of 30 cmH2O 
for 20 seconds was performed to revert any intraoperative 
lung collapse. During CPB, hypnosis was maintained with a 
propofol infusion aimed at maintaining a calculated plasma 
propofol concentration of 2.5 ug ml-1 according to the Marsh 
model13. All patients received 1 g of methylprednisolone 
intravenously before initiation of CPB according to the 
institutional protocol. Sufentanil infusion was terminated at 
the moment of skin suture. 
After arrival in the intensive care unit (ICU), a patient-
controlled analgesia pump (PCA) programmed for a 1 mg 
bolus of morphine with an administration interval locked at 
5 minutes and free demand was installed. Dipyrone (30 mg 
kg-1) was administered if patients presented persistent pain 
despite the use of PCA. Tracheal extubation was performed 
when patients were fully awake and responsive to verbal 
commands, as well as when the peripheral oximetry was 
greater than 94%, spontaneous respiratory frequency was 
greater than 10, temperature was greater than 36° C, and 
the patient was hemodynamically stable such that they were 
bleeding less than 100 ml/h. 
Ventilatory and pain score evaluation
Spirometry using an Easy One® portable spirometer 
(Niche Medical, West Leederville, Australia) was 
also performed preoperatively in the first and second 
postoperative days (POD) to measure forced vital capacity 
(FVC), forced expiratory volume in the first second (FEV1), 
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and thus the FEV1/FVC ratio. Arterial blood samples were 
collected during the preoperative period, immediately before 
surgery, after anesthesia induction, at the end of surgery, and 
in the first and second postoperative days to evaluate the 
PaO2/FiO2 ratio. Pain was evaluated using a visual numeric 
scale from zero to ten at rest, at the time of profound 
inspiration, and after cough at 3, 6, 12, 18, 24, and 36 hours 
postoperatively. Morphine cumulative consumption and 
solicitation was also evaluated at the same times listed above. 
All postoperative pain, respiratory function, and morphine 
utilization measurements were obtained by individuals who 
were not involved in patient randomization and anesthesia 
administration.
Blood samples assessed for plasma morphine 
concentrations were collected intraoperatively, immediately 
after stopping sufentanil infusion, after 5, 15, 30, and 60 
minutes, and after 3, 6, 12, 18, 24, and 36 hours in the ICU. 
The blood samples were centrifuged at 10.000 rpm for 10 
minutes, and the supernatant was frozen at - 70 ºC for later 
analysis. Plasma morphine concentrations were measured 
using a mass spectrophotometer.
Sample size and statistical analysis
A sample size of at least 36 patients was deemed 
necessary to detect a statistically significant decrease (p < 
0.05) in cumulative morphine consumption of 20% between 
the morphine and control group, assuming a standard 
deviation of 10 mg in a single-tail paired Student’s t-test 
using G Power 3 software (Heinrich-Heine-Universität 
Düsseldorf, Düsseldorf, Germany).
Statistical analyses were performed using SPSS 
16.0 software (SPSS Inc., Chicago, Ilinois). The normal 
distribution of the collected data was confirmed by means 
of the Kolmogorov-Smirnov test. Demographic and surgical 
data were compared between groups using the unpaired 
Student’s t-test. Spirometric variables were compared over 
time between the groups using repeated measures analysis of 
variance, followed by the Student-Neumann-Keuls post hoc 
test when necessary. Pain scores and cumulative morphine 
consumption were analyzed by means of the Friedman test, 
followed by the Mann-Whitney test when necessary. All 
data are presented as mean values ± standard deviation, error 
means, or as otherwise described. The significance level was 
fixed at 5%.
RESULTS
Patient characteristics and general variables are presented 
in Table 1. There were no differences between groups with 
regard to the variables represented in Table 1. Mean surgery 
duration and CPB length were similar in both groups (392 ± 
70 vs. 379 ± 91 minutes) and (98 ± 26 vs. 95 ± 38 minutes) 
(p=0.606 and p=0.780, respectively). Minimal temperature 
values were 31.3 ± 2.7°C in the control group and 30.7 ± 
2.7°C in the morphine group (p=0.456). All patients achieved 
hemodynamic stability in the immediate postoperative 
period, permitting weaning off of the vasoactive drugs within 
the first 24 hours. The total dose of sufentanil employed 
was 257.77 µg ± 81.41 in the control group and 200.87 µg 
± 55.11 in the morphine group (p= 0.012), and was related 
to the duration of surgery. Intrathecal morphine did not 
shorten the postoperative time to extubation between groups 
(396 ± 234 min in the control group and 349 min ± 175 in 
the morphine group, p=0.466). None of the patients in our 
cohort developed respiratory failure after extubation or 
needed postoperative non-invasive ventilation. All intrathecal 
punctures were successful at the first or second attempt. 
Table 1 - Sex, Age, IMC, Higgins Surgical Risk Scale, Extubation time, Surgical time, Extracorporeal duration, Minimal 
temperature at Extracorporeal Circulation between groups. Total dose of sufentanil. Values represent means ± SD. *Chi-
square Test **Independent T-student Test, p < 0.05
Control Morphine  p-value
Sex (M: F) 20:02 16:04 0.313*
Age (years) 63.8 ± 11.3 60.9 ± 7.6 0.361**
BMI (Kg/cm2) 27.1 ± 3.1 24.4 ± 3 0.071**
Higgins Surgical Risk Scale (0-5) 1.727 ± 1.08 2±1.21 0.546**
Surgery Duration (min) 392.5 ± 70.30 379,5 ± 91,00 0.606**
Tracheal Extubation Time (min) 396.5 ± 234.20 349.1± 175.10 0.466**
CPB Time (min) 98.27 ± 26.90 95.55 ± 38.26 0.790**
Minimal Temperature at CPB (°C) 31.30 ± 2.70 30.68 ± 2.66 0.456**
Total Dose of Sufentanil (µg) 257.77 ± 81.41 200.87± 55.11 0.012**
* Chi-square Test, ** Independent T Samples Test
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No cases of spinal hematoma or treatable pruritus were 
observed. All patients were discharged from the ICU without 
postoperative complications. 
Gas exchange and Spirometric Analysis
Both group presented a significant decrease in FVC 
and FEV1 during the first and second postoperative days, 
with no significant difference between the groups (p=0.068 
and 0.085, respectively). The FEV1/FVC ratio did not 
differ between groups (p=0.68), as presented in Table 2. In 
addition, the PaO2/FiO2 ratio did not differ between groups 
at any time point (p >0.05), as presented in Figure 1. 
Pain scores, morphine consumption, and plasma con-
centrations
The intensity of pain at rest and with cough was 
significantly lower in the morphine group at 12, 18, 24, and 
36 hours postoperatively when compared to the control group 
(p <0.05), as shown in panels A and C of Figure 2. With 
profound inspiration, patients in the morphine group reported 
pain levels that were significantly less intense at 12, 18, and 
24 hours after surgery (panel B of Figure 2). The venous 
morphine solicitation count was lower in the morphine group 
at 18 (control group= 108.3 ± 213.8 and morphine group= 
20.2 ± 30.3) and 24 hours (control group= 144.4 ± 251.2 
and morphine group= 32.4 ± 38.05) (p<0.05). Cumulative 
morphine consumption was also reduced in the morphine 
group at 18 (control group= 20.14 ± 17.73 mg and morphine 
group=14.10 ± 26.15 mg), 24 (control group= 27.82 ± 22.77 
mg and morphine group= 13.55 ± 10.49 mg), and 36 hours 
(control group = 38.50 ± 26.70 and morphine group= 24.30 ± 
14.59) postoperatively (Figure 3), as well as upon extubation 
Table 2 - Forced Vital Capacity (FVC), Forced Expiratory Volume in the First Second (FEV1), and FEV1/FVC ratio at 
preoperative, and first and second postoperative days (P.O.D.) *ANOVA, p< 0.05
Groups Pre-op 1st º POD 2nd POD P-value*
FVC Control Group 3.24±0.85 1.45±0.60 1.38±0.53 0.0679
Morphine Group 2.72±0. 68 1.18±0,45 1.26±0.42
FEV1 Control Group 2.41±0.73 1.06±0.46 1.02±0.54 0.085
Morphine Group 1.96±0.64 0.90±0.32 0.95±0.26
FEV1/FVC Control Group 0.75±0.11 0.77±0.19 0.79±0.35 0.685
Morphine Group 0.74±0.14 0.77±0.14 0.78±0.15
Figure 1 - PO2/FIO2 ratio between groups, p= 0.078 (means ± DP). P.O.D. 
= postoperative day. ANOVA, *p<0.05
Figure 2 - Intensity of Pain between groups (means ± SEM). A. Pain at rest (p-
value at 12, 18, 24, and 36h was 0.0095; 0.0013; 0.0089; 0.0446, respectively). 
B. Pain upon profound inspiration (p-values were 0.0291; 0.0005; 0.0004, 
respectively). C. Pain upon cough (p-values at 12, 18, 24, and 36 hours were 
0.0019; 0.0010; 0.0218; 0.0145. - Mann-Whitney Test, p<0.05)
Figure 3 - Cumulative morphine consumption between groups (means ± 
SEM). P-values at 18 and 24 hours were 0.0373 and 0.0283, respectively. 
Mann-Whitney Test, *p<0.05
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(control group= 3.32 ± 8.17 mg and morphine group= 0.15 
± 0.49 mg) (p<0.05). Plasma morphine levels were zero at 
the end of surgery in both groups. However, plasma levels 
were significantly reduced in the morphine group during the 
postoperative period 24 hours after the operation (control 
group= 15.87 ± 18.05 ng mL-1 and morphine group 4.08 ± 
5.28 ng mL-1, p=0.029), as presented in Figure 4. Nine patients 
in the control group and five patients in the morphine group 
requested rescue analgesia with dipyrone (p= 0.460).
DISCUSSION
In the present study, intrathecal morphine administration 
in patients undergoing coronary artery bypass graft 
reduced pain scores, postoperative morphine solicitation, 
and morphine consumption and its plasma concentration. 
However, despite better analgesic control, no significant 
improvements in spirometry or gas exchange were 
observed. 
Respiratory system dysfunction is the most prevalent 
organic complication after cardiac surgery, even in the 
absence of preoperative pulmonary disease1. Perioperative 
atelectasis leads to a pulmonary ventilation/perfusion 
mismatch that likely serves as a major cause of shunt and 
hypoxemia after cardiopulmonary bypass.14 The impact of 
postoperative analgesia techniques on pulmonary function 
outcome has been well studied in non-cardiac surgery, but 
few studies to date have examined this matter in cardiac 
surgery.8 A study that enrolled 113 patients submitted for 
different types of cardiac surgery observed that thoracic 
epidural analgesia (TEA) combined with general anesthesia 
followed by patient-controlled thoracic epidural analgesia 
offered no major advantages with respect to lung function, 
length of hospital stay, quality of recovery, or morbidity 
when compared to general anesthesia alone, with both groups 
followed by patient-controlled analgesia with intravenous 
morphine.15 In contrast, a meta-analysis including 15 trials 
enrolling 1.178 patients suggested that TEA significantly 
reduced the risk of pulmonary complications (OR 0.41), time 
to tracheal extubation by 4.5 hours, and analog pain scores 
at rest and with activity.9 
In the present study, intrathecal instead of epidural 
morphine was used because there is no evidence for 
analgesia superiority between them. However, the risk of 
spinal hematoma is lower with the intrathecal technique,16 
especially with the required anticoagulation prior to cardiac 
surgery.
The last two meta-analyses used to evaluate the use of 
intrathecal morphine in cardiac surgery did not reveal a 
correlation between the efficacy of pain control and better 
respiratory outcome,3,11 likely because these studies did 
not employ lung function as an end-point11. Some of these 
studies described no improvement of pain control10 or modest 
reduction of pain scores,11 with higher doses correlating 
with better postoperative analgesia17 as well as longer time 
to extubation.18 In line with the beginning of the fast-track 
era and its goal to decrease the intubation time after surgery, 
changes in anesthesia techniques and a reduction in the 
dose of intrathecal morphine were previously associated 
with a decreased time to extubation,20 with some cases 
of prolonged respiratory depression.21 A previous study 
compared intrathecal morphine doses of 250 and 500 µg and 
placebo, and showed the superiority of intrathecal analgesia, 
without alterations in gas exchange19 or an increase in time 
to extubation.22 In the present study, the selected dose of 400 
µg of morphine had no effect on time to tracheal extubation 
in the postoperative period. According to our results, use of 
low doses of intrathecal morphine can decrease the intensity 
of postoperative pain at different times, such as at rest, upon 
profound inspiration, and upon cough. This suggests that 
not only does intrathecal morphine provide better analgesia 
at rest, but also during activities that support walking, 
respiratory maneuvers, and the use of incentive spirometry. 
This is important to ensure the quality of patient recovery, 
since it has been demonstrated that respiratory physiotherapy 
may reduce rates of pulmonary complications.23-25 
Figure 4 - Plasma Morphine Levels between groups, p-value=0.029 at 24 hours. Mann-Whitney, *p<0.05
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Improved analgesia may allow for a decrease in the 
solicitation and consumption of postoperative analgesics, 
resulting in lower plasma analgesic levels, as observed in 
this study. A previous cardiac surgery study that also used 
intrathecal morphine revealed a venous consumption of 13.5 
mg at a dose of 250 µg, and a consumption of 11.7 mg of 
morphine with an intrathecal dose of 500 µg compared to 
21.7 mg in the placebo group 24 hours after the operation.22 
In a meta-analysis, 668 patients undergoing cardiac surgery 
were reported to consume 11 mg of intravenous morphine 
in intrathecal group .9 
The importance of studying the plasma concentration 
of morphine as a marker for progress in the of treatment 
of pain was considered by Bonica in 1985, but only a few 
studies have investigated this idea26 Only one study has 
been published regarding plasma morphine concentrations 
during patient control analgesia techniques,27 and no studies 
reported intrathecal morphine use in the postoperative period 
or its correlation with pain scores. In patients undergoing 
hysterectomy with postoperative PCA, an increase in 
plasma morphine levels resulted in clinical effects 6 to 
12 hours after surgery. This lag could be explained by the 
delay in morphine passing through the hematoencephalic 
barrier. After this period, a significant reduction in morphine 
consumption and pain scores was observed, and this can be 
explained by maintenance of a steady-state level of morphine 
sufficient to maintain an effective level of analgesia.27 
Mutations in the opioid µ receptor were described to support 
the interindividual variability theory in the population and its 
possible influences on the use of morphine.28-30 
Although the number of patients in our study was 
insufficient to fully evaluate the adverse effects of intrathecal 
morphine, no cases of spinal hematoma or treatable pruritus 
were observed in the present study. Previous studies utilizing 
doses between 5 -24 µg kg-1 for cardiac surgery described 
a 30% incidence of pruritus,21 which is the most common 
symptom observed after morphine treatment. Fortunately, 
this common side effect becomes severe in only 1% of 
cases.31 The absence of an intrathecal puncture in the control 
group may have limited our ability to observe adverse 
effects. 
Despite the risk of spinal hematoma, the use of 
intrathecal analgesia in cardiac surgery32 has increased. 
This increase may be explained by the demand for better 
analgesia with chest tubes, sternotomy, deambulation, and 
physiotherapy maneuvers in the absence of a trained pain 
management team and patient-control pumps. Thus, our 
study has direct clinical applications. Future studies are 
being conducted to study the effects of pain control on 
quality of life, satisfaction, and postoperative recovery, since 
no additional benefits of intrathecal morphine beyond pain 
control have been shown until now. None of these quality 
of life or recovery variables have been correlated with 
better pain scores, but a modest reduction in satisfaction 
was shown in the presence of adverse effects.33 Considering 
the risks of nerve blockade and required anticoagulation in 
cardiac surgery, further efforts are required to identify better 
pain control to ensure better patient outcomes. 
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